研究実績

A Multicenter Phase II Trial of Encorafenib, Binimetinib and Cetuximab for Early Relapsed Stage II/III BRAFV600E-mutated Colorectal Cancer: TRESBIEN trial (OGSG 2101)

Toshihiro Kudo, Shogen Boku, Atsushi Naito, Takashi Ohta, Yusuke Suwa, Ichiro Takemasa, Chiaki Inagaki, Koichi Okuya, Mitsuyoshi Tei, Masayoshi Nakanishi, Narikazu Boku, Hiroyuki Okuda, Toshifumi Yamaguchi, Shingo Noura, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh, Hironaga Satake, Yoshinori Kagawa

ASCO2026, Chicago, IL May 29 – June 2, 2026

前の記事 次の記事 一覧ページへ戻る